DK0609217T3 - Tørre farmaceutiske stivelse-iod-formuleringer - Google Patents
Tørre farmaceutiske stivelse-iod-formuleringerInfo
- Publication number
- DK0609217T3 DK0609217T3 DK92906739.5T DK92906739T DK0609217T3 DK 0609217 T3 DK0609217 T3 DK 0609217T3 DK 92906739 T DK92906739 T DK 92906739T DK 0609217 T3 DK0609217 T3 DK 0609217T3
- Authority
- DK
- Denmark
- Prior art keywords
- iodine
- starch
- dry powder
- pharmaceutical formulations
- amylose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67617091A | 1991-03-28 | 1991-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0609217T3 true DK0609217T3 (da) | 1998-03-30 |
Family
ID=24713512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92906739.5T DK0609217T3 (da) | 1991-03-28 | 1992-03-18 | Tørre farmaceutiske stivelse-iod-formuleringer |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0609217B1 (fr) |
| JP (1) | JPH06508105A (fr) |
| AT (1) | ATE163266T1 (fr) |
| AU (1) | AU664174B2 (fr) |
| CA (1) | CA2106954C (fr) |
| DE (1) | DE69224481T2 (fr) |
| DK (1) | DK0609217T3 (fr) |
| ES (1) | ES2114934T3 (fr) |
| GR (1) | GR3026425T3 (fr) |
| RU (1) | RU2110265C1 (fr) |
| WO (1) | WO1992017190A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6019970A (en) * | 1985-07-31 | 2000-02-01 | Ghent William R. | Treatment of iodine deficiency diseases |
| US5955101A (en) * | 1991-03-28 | 1999-09-21 | 943038 Ontario Inc. | Dry starch-iodine pharmaceutical formulations |
| US5910318A (en) * | 1991-03-28 | 1999-06-08 | 943038 Ontario Inc. | Treatment of iodine deficiency diseases |
| RU2151611C1 (ru) * | 1999-06-18 | 2000-06-27 | Общество с ограниченной ответственностью НАУЧНО-ПРОИЗВОДСТВЕННОЕ ПРЕДПРИЯТИЕ "МЕДБИОФАРМ" | Средство для регулирования йодного обмена или профилактики йоддефицитных состояний |
| HUP0105261A2 (hu) * | 2001-12-06 | 2003-08-28 | Szilveszter Török | Természetes anyagú, szerves kötésű jódtartalmú készítmények jód élő szervezetbe történő bevitelére, továbbá eljárások azok előállítására |
| US20080153695A1 (en) * | 2005-02-07 | 2008-06-26 | Kayo Hosoya | Adsorbent Containing Alpha-1,4-Glucan and Process for Producing the Same |
| GB201804011D0 (en) * | 2018-03-13 | 2018-04-25 | Givaudan Sa | Improvements in or relating to organic compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH124440A (de) * | 1926-07-26 | 1928-02-01 | Otto Dr Med Stiner | Verfahren zur Darstellung eines zu Arzneizwecken dienenden Nähr- oder Futtermittels, welches Jod in dauernd gleichbleibender Verteilung chemisch gebunden enthält. |
| US2022729A (en) * | 1933-07-19 | 1935-12-03 | Mackie Henkels Inc | Stable colloidal solution of iodine |
| US2927058A (en) * | 1957-07-12 | 1960-03-01 | Ibc Res Lab Inc | Method of producing antisepsis by beta amylose trhodide |
| US4010259A (en) * | 1975-07-17 | 1977-03-01 | Johansson J A Olof | Disinfectants containing iodine complexed to a hydrophilic organic carrier |
| US4214059A (en) * | 1978-06-12 | 1980-07-22 | The Purdue Frederick Company | Method for the production of iodophor powders |
| DE3312431A1 (de) * | 1983-04-07 | 1984-10-11 | B. Braun Melsungen Ag, 3508 Melsungen | Pvp-iod-wundpuder mit synergistisch wirkender pudergrundlage |
| HUT38684A (en) * | 1983-11-29 | 1986-06-30 | Avtex Fibers Inc | Fibrous material of germicide activity |
| US5171582A (en) * | 1985-07-31 | 1992-12-15 | Ghent William R | Treatment of iodine deficiency diseases |
-
1992
- 1992-03-18 WO PCT/CA1992/000115 patent/WO1992017190A1/fr active IP Right Grant
- 1992-03-18 DE DE69224481T patent/DE69224481T2/de not_active Expired - Fee Related
- 1992-03-18 RU RU93056613/14A patent/RU2110265C1/ru not_active IP Right Cessation
- 1992-03-18 DK DK92906739.5T patent/DK0609217T3/da active
- 1992-03-18 AU AU15654/92A patent/AU664174B2/en not_active Ceased
- 1992-03-18 EP EP92906739A patent/EP0609217B1/fr not_active Expired - Lifetime
- 1992-03-18 AT AT92906739T patent/ATE163266T1/de not_active IP Right Cessation
- 1992-03-18 CA CA002106954A patent/CA2106954C/fr not_active Expired - Fee Related
- 1992-03-18 ES ES92906739T patent/ES2114934T3/es not_active Expired - Lifetime
- 1992-03-18 JP JP4506317A patent/JPH06508105A/ja active Pending
-
1998
- 1998-03-20 GR GR980400615T patent/GR3026425T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2110265C1 (ru) | 1998-05-10 |
| DE69224481T2 (de) | 1998-10-01 |
| ATE163266T1 (de) | 1998-03-15 |
| JPH06508105A (ja) | 1994-09-14 |
| GR3026425T3 (en) | 1998-06-30 |
| ES2114934T3 (es) | 1998-06-16 |
| CA2106954A1 (fr) | 1992-09-29 |
| WO1992017190A1 (fr) | 1992-10-15 |
| CA2106954C (fr) | 2002-10-22 |
| DE69224481D1 (de) | 1998-03-26 |
| AU1565492A (en) | 1992-11-02 |
| AU664174B2 (en) | 1995-11-09 |
| EP0609217A1 (fr) | 1994-08-10 |
| EP0609217B1 (fr) | 1998-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK166480B1 (da) | Farmaceutisk pulver- eller tabletpraeparat indeholdende ibuprofen og en fremgangsmaade til fremstilling heraf | |
| HUP0003173A2 (hu) | A GLP-1 vagy analógjainak alkalmazása szívizominfarktus kezelésére használható gyógyszerkészítmények előállítására | |
| ES2227318T3 (es) | Extracto estable y mejorado de hypericum perforatum l., un procedimiento para su preparacion y su utilizacion como medicamento topico. | |
| YU48583B (sh) | Postupak za pripremanje formulacije u obliku pilule za oralno davanje | |
| AR202034A1 (es) | Procedimiento para preparar polvo farmaceutico dispersible para administracion oral de sitosteroles | |
| NO146456C (no) | Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel | |
| NZ507566A (en) | Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants | |
| JPS6289619A (ja) | 安定なナトリウムアスピリン錠剤組成物 | |
| DK0609217T3 (da) | Tørre farmaceutiske stivelse-iod-formuleringer | |
| ES2654306T3 (es) | Preparación farmacéutica sólida que contiene levotiroxina | |
| ES2230889T3 (es) | Acetaminofeno de liberacion prolongada. | |
| HUP9701777A2 (hu) | Raloxifene alkalmazása mellrák megelőzésére alkalmas gyógyszerkészítmények előállítására | |
| KR910014124A (ko) | 콜로이달 비스무트 서브시트레이트(cbs)를 함유하는 삼킬수 있는 투여 단위 | |
| US5955101A (en) | Dry starch-iodine pharmaceutical formulations | |
| RU93056613A (ru) | Сухая крахмально-йодистая фармацевтическая композиция, способ ее получения и применения | |
| SE7704764L (sv) | Framstellning av oral berarebas jemte derav framstellda doseringsenheter | |
| JP2013216632A (ja) | 医薬組成物 | |
| ES2274318T3 (es) | Compuestos cuaternarios que comprenden propolis como sustancia activa. | |
| IT1314199B1 (it) | Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita' | |
| AU1452402A (en) | Novel pharmaceutical formulation in the form of cellulose capsules suitable for benzimidazole derivatives | |
| US5910318A (en) | Treatment of iodine deficiency diseases | |
| GB950162A (en) | Medicines for the treatment of hepatic disorders | |
| Gandigawad et al. | Evaluation of anti-inflammatory activity of ethanolic extract of Gmelina arborea in experimental acute and sub-acute inflammatory models in wistar rats | |
| GB1292496A (en) | Dosage units of contraceptive preparations for human use | |
| GB914512A (en) | Novel therapeutic compositions |